Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

829.74 -17.09 (-2.02%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Several AI stocks among the S&P 500's best performers. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
These stalwart companies could help you safely grow your wealth. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy in June
Healthcare businesses tend to hold up through various economic cycles. 
Via The Motley Fool
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments. 
Via InvestorPlace
This Is Massive News for Eli Lilly Investors
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate. 
Via The Motley Fool
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
Via Benzinga
Chart Of The Day: Eli Lilly - More New Highs
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. 
Via Talk Markets
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
First Half 2024 -- That's A Wrap
With the first half of 2024 now behind us, here is a snapshot of asset class performance across the financial landscape using US-listed ETFs and other exchange-traded products. 
Via Talk Markets
Topics ETFs
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
These healthcare stocks have clear paths to growth over the next few years. 
Via The Motley Fool
Stock Split Watch: Is Eli Lilly Next?
Eli Lilly's revenue has climbed, thanks to high demand for its weight loss drugs. 
Via The Motley Fool
AI Play Arista Networks At All-Time High, Leads List Of Newcomers To IBD Top Stock Lists Like IBD 50, Other Premium Lists
Arista Networks' EPS growth ranged up to 49% over the past four quarters. It was among nine stocks added to IBD top stock lists Thursday. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the world's most populous country. The competitive landscape and regulatory... 
Via Benzinga
3 Promising Stocks That Can Turn $10K Into $1 Million
$10,000 dollars invested in these high-growth stocks can legitimately grow into one million with shorter timelines than expected overall. 
Via InvestorPlace
7 A-Rated Stocks for Your June Buy List
While there's no bad time to buy A-rated stocks, these equities represent companies that are must-own picks for June 2024. 
Via InvestorPlace
3 Valuable Stocks That Are Worth the Expensive Price Tag
Putting your hard-earned money into the stock market? Here are expensive stocks worth buying for the long-term. 
Via InvestorPlace
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Active Fund Managers Bet These 6 Stocks Will Trade Near All-Time Highs
Active fund managers making large bets on momentum plays indicate confidence that Big Tech's rally has legs for the remainder of 2024. 
Via Benzinga
The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition
The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit. 
Via InvestorPlace
Better Growth Stock: Archer Aviation or Viking Therapeutics?
Which one of these potential disruptors is the better buy? 
Via The Motley Fool
2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked
The stock may seem expensive right now, but that may not be the case in a few years. 
Via The Motley Fool
Alphabet Among Stocks Hitting All-Time High Tuesday: See Which Stocks Just Came On IBD's Top Stock Screens
Google-parent Alphabet hit a fresh high at 184.03 Tuesday. Its earnings rose the past year to a 53% surge to $1.74 per share last quarter. 
Via Investor's Business Daily
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, raising concerns for similar weight loss drugs. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.